Pikora C A, Sullivan J L, Panicali D, Luzuriaga K
Department of Pediatrics, University of Massachusetts Medical Center, Worcester 01605, USA.
J Exp Med. 1997 Apr 7;185(7):1153-61. doi: 10.1084/jem.185.7.1153.
High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection.
在成人初次感染后的数周内,已检测到识别HIV-1实验室株基因产物的细胞毒性T淋巴细胞前体(CTLp)的高频率。相比之下,在6个月以下的婴儿中很少检测到HIV-1特异性CTLp。为了验证使用表达实验室株env基因产物的靶细胞可能会限制早期婴儿期HIV-1 env特异性CTLp检测的假说,构建了表达来自4名垂直感染婴儿早期分离株的HIV-1 env基因的重组痘苗病毒(vv)。使用有限稀释法连续测量识别感染了表达早期分离株env基因产物的vv和HIV-1 IIIB的靶细胞的CTLp频率,随后用抗CD3单克隆抗体进行体外刺激。在一名婴儿中,早期分离株env特异性CTLp的检测先于IIIB特异性CTLp的检测。在两名婴儿中,在6个月龄时检测到识别HIV-1 IIIB和婴儿分离株env的CTLp。在第四名婴儿中,在12个月龄时同时检测到HIV-1 IIIB env和早期分离株env特异性CTLp。这些结果证明,年幼婴儿能够产生HIV-1特异性CTL反应,并为新生儿接种疫苗以预防HIV-1传播的概念提供了支持。然而,在一些年幼婴儿中检测到的型特异性CTL的早期优势表明,使用基于HIV-1实验室株的疫苗可能无法预防垂直感染。